FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072960422> ?p ?o ?g. }

• W2072960422 endingPage "1429" @default.
• W2072960422 startingPage "1424" @default.
• W2072960422 abstract "Thrombocytopenia is common in advanced-stage liver disease and is partly caused by inadequate thrombopoietin (TPO) production in the failing liver. Treatment of chronic hepatitis C with interferon alfa (IFN-α) often induces thrombocytopenia, sometimes even leading to discontinuation of treatment. TPO regulation in response to IFN-α–induced thrombocytopenia was studied in patients with chronic hepatitis C with and without cirrhosis (Child A). An in vitro culture system with HepG2 cells was used to demonstrate any direct effects of IFN-α on TPO mRNA expression, TPO synthesis, or TPO secretion from liver cells. Thrombocyte count was lower (U test: P < .05) in patients with hepatitis C cirrhosis compared with patients with chronic hepatitis C without cirrhosis before IFN therapy, and decreased in both patient groups (Wilcoxon matched-pairs test: P < .05) on IFN therapy, the median decrease in both groups being comparable (noncirrhotic patients, 35%; cirrhotic patients, 32%; U test: P = .57). TPO levels rose in noncirrhotic patients (Wilcoxon matched-pairs test: P < .05), but not in patients with cirrhosis (noncirrhotic patients' median increase: 43% vs. cirrhotic patients' median decrease: 5%; U test: P < .001). Even in patients without cirrhosis, the increase in TPO levels was relatively small for the decrease in platelet count. No effect of IFN-α could be demonstrated on TPO mRNA expression in vitro, but TPO secretion from liver cells was significantly reduced. Lower platelet counts but similar TPO levels in patients with chronic hepatitis C and cirrhosis compared with noncirrhotic patients and a moderate increase in TPO levels in noncirrhotic patients with a missing increase in cirrhotic patients during IFN-α–induced thrombocytopenia provide further evidence for an impairment of TPO production in patients with cirrhosis and during IFN therapy. Recombinant human TPO could be of value in patients developing severe thrombocytopenia under IFN-α therapy." @default.
• W2072960422 created "2016-06-24" @default.
• W2072960422 creator A5022345230 @default.
• W2072960422 creator A5037939930 @default.
• W2072960422 creator A5039105126 @default.
• W2072960422 creator A5042598645 @default.
• W2072960422 creator A5054418485 @default.
• W2072960422 creator A5061474122 @default.
• W2072960422 creator A5073197069 @default.
• W2072960422 creator A5073880705 @default.
• W2072960422 creator A5074942131 @default.
• W2072960422 creator A5082570951 @default.
• W2072960422 date "1998-11-01" @default.
• W2072960422 modified "2023-10-15" @default.
• W2072960422 title "Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C" @default.
• W2072960422 cites W101263417 @default.
• W2072960422 cites W117742811 @default.
• W2072960422 cites W1551925997 @default.
• W2072960422 cites W1983612778 @default.
• W2072960422 cites W1987686674 @default.
• W2072960422 cites W1996573476 @default.
• W2072960422 cites W2003600359 @default.
• W2072960422 cites W2007979457 @default.
• W2072960422 cites W2016730958 @default.
• W2072960422 cites W2018587749 @default.
• W2072960422 cites W2020602778 @default.
• W2072960422 cites W2032897633 @default.
• W2072960422 cites W2038570077 @default.
• W2072960422 cites W2055270948 @default.
• W2072960422 cites W2059052465 @default.
• W2072960422 cites W2059786861 @default.
• W2072960422 cites W2067284095 @default.
• W2072960422 cites W2082463095 @default.
• W2072960422 cites W2260183312 @default.
• W2072960422 cites W2288636678 @default.
• W2072960422 cites W2293557188 @default.
• W2072960422 cites W2318639814 @default.
• W2072960422 cites W2335968781 @default.
• W2072960422 cites W2417688184 @default.
• W2072960422 cites W2474650552 @default.
• W2072960422 cites W29651041 @default.
• W2072960422 cites W350217275 @default.
• W2072960422 doi "https://doi.org/10.1002/hep.510280535" @default.
• W2072960422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9794931" @default.
• W2072960422 hasPublicationYear "1998" @default.
• W2072960422 type Work @default.
• W2072960422 sameAs 2072960422 @default.
• W2072960422 citedByCount "92" @default.
• W2072960422 countsByYear W20729604222012 @default.
• W2072960422 countsByYear W20729604222013 @default.
• W2072960422 countsByYear W20729604222014 @default.
• W2072960422 countsByYear W20729604222015 @default.
• W2072960422 countsByYear W20729604222016 @default.
• W2072960422 countsByYear W20729604222017 @default.
• W2072960422 countsByYear W20729604222019 @default.
• W2072960422 countsByYear W20729604222020 @default.
• W2072960422 countsByYear W20729604222021 @default.
• W2072960422 countsByYear W20729604222022 @default.
• W2072960422 crossrefType "journal-article" @default.
• W2072960422 hasAuthorship W2072960422A5022345230 @default.
• W2072960422 hasAuthorship W2072960422A5037939930 @default.
• W2072960422 hasAuthorship W2072960422A5039105126 @default.
• W2072960422 hasAuthorship W2072960422A5042598645 @default.
• W2072960422 hasAuthorship W2072960422A5054418485 @default.
• W2072960422 hasAuthorship W2072960422A5061474122 @default.
• W2072960422 hasAuthorship W2072960422A5073197069 @default.
• W2072960422 hasAuthorship W2072960422A5073880705 @default.
• W2072960422 hasAuthorship W2072960422A5074942131 @default.
• W2072960422 hasAuthorship W2072960422A5082570951 @default.
• W2072960422 hasBestOaLocation W20729604221 @default.
• W2072960422 hasConcept C109159458 @default.
• W2072960422 hasConcept C126322002 @default.
• W2072960422 hasConcept C203014093 @default.
• W2072960422 hasConcept C2776178377 @default.
• W2072960422 hasConcept C2776455275 @default.
• W2072960422 hasConcept C2777075537 @default.
• W2072960422 hasConcept C2777214474 @default.
• W2072960422 hasConcept C2777863708 @default.
• W2072960422 hasConcept C2778715236 @default.
• W2072960422 hasConcept C2781228144 @default.
• W2072960422 hasConcept C28328180 @default.
• W2072960422 hasConcept C2909179924 @default.
• W2072960422 hasConcept C54355233 @default.
• W2072960422 hasConcept C71924100 @default.
• W2072960422 hasConcept C86803240 @default.
• W2072960422 hasConcept C89560881 @default.
• W2072960422 hasConcept C90924648 @default.
• W2072960422 hasConceptScore W2072960422C109159458 @default.
• W2072960422 hasConceptScore W2072960422C126322002 @default.
• W2072960422 hasConceptScore W2072960422C203014093 @default.
• W2072960422 hasConceptScore W2072960422C2776178377 @default.
• W2072960422 hasConceptScore W2072960422C2776455275 @default.
• W2072960422 hasConceptScore W2072960422C2777075537 @default.
• W2072960422 hasConceptScore W2072960422C2777214474 @default.
• W2072960422 hasConceptScore W2072960422C2777863708 @default.
• W2072960422 hasConceptScore W2072960422C2778715236 @default.
• W2072960422 hasConceptScore W2072960422C2781228144 @default.
• W2072960422 hasConceptScore W2072960422C28328180 @default.

• next